62 related articles for article (PubMed ID: 19505834)
1. Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.
Fredheim OM; Skurtveit S; Breivik H; Borchgrevink PC
Eur J Pain; 2010 Mar; 14(3):289-94. PubMed ID: 19505834
[TBL] [Abstract][Full Text] [Related]
2. Childhood trauma and the use of opioids and other prescription analgesics in adolescence and young adulthood: The HUNT Study.
Baumann-Larsen M; Storheim K; Stangeland H; Zwart JA; Wentzel-Larsen T; Skurtveit S; Dyb G; Stensland SØ
Pain; 2024 Jun; 165(6):1317-1326. PubMed ID: 38126936
[TBL] [Abstract][Full Text] [Related]
3. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
Bramness JG; Furu K; Engeland A; Skurtveit S
Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
[TBL] [Abstract][Full Text] [Related]
4. "Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology.
Jani M; Yimer BB; Selby D; Lunt M; Nenadic G; Dixon WG
Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):651-660. PubMed ID: 36718594
[TBL] [Abstract][Full Text] [Related]
5. Opioid epidemic in the United States.
Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
[TBL] [Abstract][Full Text] [Related]
6. A nationwide study on consumption of opioid analgesics in Iran from 2000 to 2018.
Kalantar A; Rezaei M; Jafarzadeh Kohneloo A; Taghizadeh-Ghehi M
Int J Clin Pharm; 2023 Apr; 45(2):397-405. PubMed ID: 36469216
[TBL] [Abstract][Full Text] [Related]
7. Injury Prevention and long-term Outcomes following Trauma-the IPOT project: a protocol for prospective nationwide registry-based studies in Norway.
Stenehjem JS; Røise O; Nordseth T; Clausen T; Natvig B; O Skurtveit S; Eken T; Kristiansen T; Gran JM; Rosseland LA
BMJ Open; 2021 May; 11(5):e046954. PubMed ID: 34006552
[TBL] [Abstract][Full Text] [Related]
8. Trends in opioid prescribing in Estonia (2011-2017).
Uusküla A; Raag M; Kurvits K; Laius O; Uusküla M; Oselin K
Pharmacol Res Perspect; 2020 Apr; 8(2):e00577. PubMed ID: 32232953
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Opioid Use in the 12 Months Following Geriatric Fragility Fractures: A Population-Based Cohort Study.
Torchia MT; Munson J; Tosteson TD; Tosteson ANA; Wang Q; McDonough CM; Morgan TS; Bynum JPW; Bell JE
J Am Med Dir Assoc; 2019 Mar; 20(3):298-304. PubMed ID: 30824217
[TBL] [Abstract][Full Text] [Related]
10. Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.
Raknes G; Småbrekke L
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):685-693. PubMed ID: 28370746
[TBL] [Abstract][Full Text] [Related]
11. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults.
Guerriero F
World J Clin Cases; 2017 Mar; 5(3):73-81. PubMed ID: 28352631
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects.
Hagelberg NM; Fihlman M; Hemmilä T; Backman JT; Laitila J; Neuvonen PJ; Laine K; Olkkola KT; Saari TI
Pharmacol Res Perspect; 2016 Dec; 4(6):e00271. PubMed ID: 28097004
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Approaches for the Management of Persistent Pain in Older Adults: What Nurses Need to Know.
Guerriero F; Bolier R; Van Cleave JH; Reid MC
J Gerontol Nurs; 2016 Dec; 42(12):49-57. PubMed ID: 27898136
[TBL] [Abstract][Full Text] [Related]
14. National consumption of opioid and nonopioid analgesics in Croatia: 2007-2013.
Krnic D; Anic-Matic A; Dosenovic S; Draganic P; Zezelic S; Puljak L
Ther Clin Risk Manag; 2015; 11():1305-14. PubMed ID: 26357478
[TBL] [Abstract][Full Text] [Related]
15. Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.
Samuelsen PJ; Slørdal L; Mathisen UD; Eggen AE
BMC Pharmacol Toxicol; 2015 Jun; 16():16. PubMed ID: 26048167
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of controlled prescriptions with a diagnosis of surgical intervention.
Akıcı A; Uğurlu MÜ; Topçu İ; Yılmaz H; Demircan D
Ulus Cerrahi Derg; 2013; 29(1):11-6. PubMed ID: 25931835
[TBL] [Abstract][Full Text] [Related]
17. Use of drugs subject to controlled prescriptions: a retrospective analysis.
Demircan D; Gülmez SE; Dönertaş B; Topcu I; Yılmaz H; Berkman K; Akıcı A
Balkan Med J; 2013 Mar; 30(1):46-53. PubMed ID: 25207068
[TBL] [Abstract][Full Text] [Related]
18. An overview of the patterns of prescription opioid use, costs and related harms in Australia.
Blanch B; Pearson SA; Haber PS
Br J Clin Pharmacol; 2014 Nov; 78(5):1159-66. PubMed ID: 24962372
[TBL] [Abstract][Full Text] [Related]
19. Changes in trends and pattern of strong opioid prescribing in primary care.
Zin CS; Chen LC; Knaggs RD
Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
[TBL] [Abstract][Full Text] [Related]
20. Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study.
Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L
BMC Pharmacol Toxicol; 2014 Mar; 15():17. PubMed ID: 24646721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
